InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Dandekar Atul. Director active across 1 company, notably Maze Therapeutics, Inc.. In total, 2 filings have been published. Split: 0 buy · 1 sell. Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations